Accessibility Statement
Last reviewed: August 3, 2026
USA Premium Peptides is committed to making www.usapremiumpeptides.com usable by as many people as possible, including people who use assistive technology such as screen readers, screen magnification, voice recognition, or keyboard-only navigation.
Standard We Target
We aim to meet the Web Content Accessibility Guidelines (WCAG) 2.1, Level AA, the standard most commonly referenced under the Americans with Disabilities Act (ADA) for websites. This is an ongoing effort rather than a one-time certification: as we add or change pages, we review them against these guidelines.
Measures We've Taken
- Semantic HTML headings and landmarks so screen readers can navigate the page structure.
- Descriptive alt text on product and content images.
- A color palette chosen for sufficient contrast between text and background.
- Interactive elements (menus, forms, cart, checkout) built to be operable by keyboard, not just mouse or touch.
- Text that resizes properly when a visitor increases their browser's zoom or font size.
Known Limitations
No website is perfectly accessible to everyone. We are aware that some third-party embedded content (such as payment and checkout flows hosted by our commerce platform) is outside our direct control, though our platform provider maintains its own accessibility program. If you encounter a barrier anywhere on this site, we want to know about it so we can address it.
Feedback & Accommodation Requests
If you use assistive technology and have difficulty accessing any part of this site, or if you need information in an alternate format, please contact us:
- Email: info@usapremiumpeptides.com
- Contact form: Contact Us
Please describe the specific page and issue you encountered. We aim to respond within 5 business days and to correct verified accessibility barriers as quickly as we reasonably can.
Ongoing Effort
Accessibility is an ongoing process. We review this statement periodically and update it as our site, and the standards it targets, evolve.